Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Seagen Inc (NQ: SGEN ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Dec 13, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 228.91 (1) Ask (Size) 228.96 (22) Prev. Close 228.74 Today's Range N/A - N/A 52wk Range 191.10 - 228.94 Shares Outstanding 181,934,500 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 3 Steal-of-a-Deal Stocks to Snap Up Right Now February 26, 2024 Here are three steal-of-a-deal stocks that offer meaningful upside for investors looking for stocks that are on sale now. Via InvestorPlace Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment February 22, 2024 Pfizer Inc (NYSE: PFE) is among the many pharmaceutical companies that turned to oncology in response to sinking demand for its COVID-19 products and near patent expiration dates for its several... Via Benzinga Topics Intellectual Property Exposures COVID-19 Intellectual Property Performance More News Read More Get Rich Quick with These 7 Growth Stocks to Buy Now February 20, 2024 Via InvestorPlace 7 Dividend Stocks to Buy at a 52-Week Low February 12, 2024 Via InvestorPlace Pfizer’s 2024 Comeback: A Dividend Gem in the Pharma Market February 01, 2024 Via InvestorPlace Looking Into Seagen's Recent Short Interest December 13, 2023 Via Benzinga Seagen Inc. (NASDAQ: SGEN) is a Leading Gainer in 12/12 Morning Trading December 12, 2023 Via Investor Brand Network What the Options Market Tells Us About Seagen December 11, 2023 Via Benzinga 3 Pharma Stocks Could Be the Pills Your Portfolio Needs January 18, 2024 Via InvestorPlace How To Earn $500 A Month From Pfizer Stock January 02, 2024 Via Benzinga Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 December 29, 2023 Via Benzinga 3 Stocks That Are About to Get Absolutely Crushed December 14, 2023 Via InvestorPlace $100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today December 07, 2023 Via Benzinga Pfizer's 2030 Vision Bolstered By Seagen Deal, Analyst Cuts Price Target Amid Conservative 2024 Forecast December 14, 2023 Via Benzinga Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years? December 14, 2023 Via The Motley Fool 3 Sleepy Stocks Ready to Wake up in 2024 December 13, 2023 Via InvestorPlace Pfizer's Dividend Yield Is 5.7%, Plus Humana And Shake Shack On CNBC's 'Final Trades' December 13, 2023 Via Benzinga Pfizer Stock Tumble Steepens As Seagen Guidance Update Disappoints December 13, 2023 Via Investor's Business Daily Why Is US Pharma Giant Pfizer Stock Trading Lower Today? December 13, 2023 Via Benzinga Pfizer Clears Required Regulatory Hurdles To Complete $43B Seagen Acquisition December 12, 2023 Via Benzinga Bristol Myers Squibb Further Diversifies Oncology Portfolio With Mega $8.4B Deal December 12, 2023 Via Benzinga ADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy Combination Delivers 100% Progression Free Survival at 12 months in Phase 2 Trial of Patients with Early Stage Classical Hodgkin Lymphoma December 10, 2023 From Seagen Inc. Via Business Wire 3 Blue-Chip Stocks Set to Make a Comeback in 2024 December 08, 2023 Via InvestorPlace TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer December 06, 2023 From Seagen Inc. Via Business Wire ImmunoGen Stock Nearly Doubled On Thursday: What Happened? November 30, 2023 Via Talk Markets Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.